PULM
Pulmatrix, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C+
Company Profile
CEO
Peter Ludlum
IPO Date
2014-03-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Pulmatrix, Inc.
CEO
Peter Ludlum
IPO Date
2014-03-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 34,900 |
| $0.00 |
| 30 Jan 2023 | Batycky Richard P. | director | A-Award | Acquired | 1,700 | $0.00 |
| 30 Jan 2023 | Varadan Anand | director | A-Award | Acquired | 1,700 | $0.00 |
| 30 Jan 2023 | Cabell Christopher | director | A-Award | Acquired | 1,700 | $0.00 |
| 30 Jan 2023 | Bazemore Todd | director | A-Award | Acquired | 1,700 | $0.00 |
| 30 Jan 2023 | Higgins Michael J | director | A-Award | Acquired | 2,436 | $0.00 |
| 31 Jan 2022 | Batycky Richard P. | director | A-Award | Acquired | 22,100 | $0.37 |
| 31 Jan 2022 | Cabell Christopher | director | A-Award | Acquired | 22,100 | $0.37 |
| 31 Jan 2022 | Higgins Michael J | director | A-Award | Acquired | 36,833 | $0.37 |